Mesothelioma Cancer Centers
University of Wisconsin Carbone Cancer Center
Doctors Affiliated with this Treatment Facility
The Carbone Cancer Center at the University of Wisconsin treats mesothelioma with their multidisciplinary team of pulmonologists, integrative health experts and thoracic, medical and surgical oncologists. They treat more than 400 patients a year with their leading-edge technology and treatment methods.
As Wisconsin’s only comprehensive cancer center, Carbone offers diagnostic testing like CT-guided technology for needle localization, as well as bronchoscopy and mediastinoscopy, which help to determine the staging of lung cancers. The center specializes in treatments such as chemotherapy, radiation therapy and minimally invasive surgeries like video-assisted thoracoscopic surgery, and methods of treatment are determined by the team of experts at The Carbone Cancer Center. Palliative lung procedures are also available, including treatment for pleural effusions, which is a common symptom of mesothelioma.
The center has a Lung Cancer Task Force, who works to raise funds for the research programs at the Carbone Cancer Center. Their clinical trials and research include groundbreaking treatment options that may not be available at other hospitals. More than 250 clinical trials are available for enrollment at the center, and the team of physicians can assess patient cases and help them decide if emerging treatment options are a viable route.
- Endobronchial stents
- Lung surgery
- Palliative lung procedures
- Photodynamic therapy (PDT)
- Radiation therapy
- Video-assisted thoracoscopic surgery (VATS)
- National Cancer Institute (NCI) Comprehensive Cancer Center
- Gold Seal of Approval from the Joint Commission
Mesothelioma Clinical Trials at University of Wisconsin Carbone Cancer Center
The following clinical trials are in progress or actively recruiting participants at University of Wisconsin Carbone Cancer Center:
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
Conditions: Advanced Malignant Solid Neoplasm; Advanced Peritoneal Malignant Mesothelioma; Advanced Pleural Malignant Mesothelioma; Recurrent Peritoneal Malignant Mesothelioma; Recurrent Pleural Malignant Mesothelioma; Refractory Malignant Solid Neoplasm; Unresectable Solid Neoplasm Last Updated: June 10, 2019 Status: Recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette